Cargando…
CHARACTERISTICS and considerations in the medical treatment of COVID‐19 in children
It is rare for children to be in serious condition or die from coronavirus disease 2019 (COVID‐19) caused by the 2019 novel coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2]) except for those with underlying diseases such as chronic lung disease (including asthma), cardiovasc...
Autores principales: | Imai, Kazunori, Matsushima, Asako, Saitoh, Shinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675523/ https://www.ncbi.nlm.nih.gov/pubmed/33230418 http://dx.doi.org/10.1002/ams2.597 |
Ejemplares similares
-
COVID-19: Neurological Considerations in Neonates and Children
por: Stafstrom, Carl E., et al.
Publicado: (2020) -
Considerations for vaccinating children against COVID-19
por: Hart, John D, et al.
Publicado: (2023) -
Cardiovascular manifestations and treatment considerations in COVID-19
por: Kang, Yu, et al.
Publicado: (2020) -
Respiratory Care Considerations for Children with Medical Complexity
por: Chiang, Jackie, et al.
Publicado: (2017) -
Pharmacotherapy consideration of thrombolytic medications in COVID-19-associated ARDS
por: Amini, Shahideh, et al.
Publicado: (2022)